[1] Giaretti W, Monteghirfo S, Pentenero M, et al. Chromosomal instability, DNA index, dysplasia, and subsite in oral premalignancy as intermediate endpoints of risk of cancer [J]. Cancer Epidemiol Biomarkers Prev, 2013, 22(6): 1133-1141. [2] Kim DW, Kim CG. Effects of DNA ploidy and S-phase fraction on fluorine-18 FDG uptake of primary breast cancer lesions [J]. Clin Breast Cancer, 2013, 13(3): 196-201. [3] Donadini A, Maffei M, Cavallero A, et al. Oral cancer genesis and progression: DNA near-diploid aneuploidization and endoreduplication by high resolution flow cytometry [J]. Cell Oncol, 2010, 32(5-6): 373-383. [4] Klanrit P, Sperandio M, Brown AL, et al. DNA ploidy in proliferative verrucous leukoplakia [J]. Oral Oncol, 2007, 43(3): 310-316. [5] Mattila R, Alanen K, Syrjanen S. Desmocollin expression in oral atrophic lichen planus correlates with clinical behavior and DNA content [J]. J Cutan Pathol, 2008, 35(9): 832-838. [6] Santos-Silva AR, Ribeiro AC, Soubhia AM, et al. High incidences of DNA ploidy abnormalities in tongue squamous cell carcinoma of young patients: an international collaborative study [J]. Histopathology, 2011, 58(7): 1127-1135. [7] Maraki D, Becker J, Boecking A. Cytologic and DNA-cytometric very early diagnosis of oral cancer [J]. J Oral Pathol Med, 2004, 33(7): 398-404. [8] Yu C, Zhang X, Huang Q, et al. High-fidelity DNA histograms in neoplastic progression in Barrett's esophagus [J]. Lab Invest, 2007, 87(5): 466-472. [9] Giaretti W, Pentenero M, Gandolfo S, et al. Chromosomal instability, aneuploidy and routine high-resolution DNA content analysis in oral cancer risk evaluation[J]. Future Oncol,2012,8(10): 1257-1271. [10] van Zyl AW, van Heerden MB, Langenegger E, et al. Correlation between dysplasia and ploidy status in oral leukoplakia [J]. Head Neck Pathol, 2012, 6(3): 322-327. [11] Khanna R, Agarwal A, Khanna S, et al. S-phase fraction and DNA ploidy in oral leukoplakia [J]. ANZ J Surg, 2010, 80(7-8): 548-551. [12] Torres-Rendon A, Stewart R, Craig GT, et al. DNA ploidy analysis by image cytometry helps to identify oral epithelial dysplasias with a high risk of malignant progression [J]. Oral Oncol, 2009, 45(6): 468-473. [13] Bremmer JF, Brakenhoff RH, Broeckaert MA, et al. Prognostic value of DNA ploidy status in patients with oral leukoplakia [J]. Oral Oncol, 2011, 47(10): 956-960. [14] Giaretti W, Monteghirfo S, Pentenero M, et al. Chromosomal instability, DNA index, dysplasia, and subsite in oral premalignancy as intermediate endpoints of risk of cancer [J]. Cancer Epidemiol Biomarkers Prev, 2013, 22(6): 1133-1141. [15] Hass HG, Schmidt A, Nehls O, et al. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)-potential implications for clinical management and treatment decisions [J]. Oral Oncol, 2008, 44(1): 78-85. [16] Fleskens SJ, Takes RP, Otte-Höller I, et al. Simultaneous assessment of DNA ploidy and biomarker expression in paraffin-embedded tissue sections [J]. Histopathology, 2010, 57(1): 14-26. [17] Gouvêa AF, Santos Silva AR, Speight PM, et al. High incidence of DNA ploidy abnormalities and increased Mcm2 expression may predict malignant change in oral proliferative verrucous leukoplakia [J]. Histopathology, 2013, 62(4): 551-562. [18] Laytragoon-Lewin N, Chen F, Castro J, et al. DNA content and methylation of p16, DAPK and RASSF1A gene in tumour and distant, normal mucosal tissue of head and neck squamous cell carcinoma patients[J]. Anticancer Res, 2010, 30(11): 4643-4648. [19] Hirshberg A, Yarom N, Amariglio N, et al. Detection of non-diploid cells in premalignant and malignant oral lesions using combined morphological and FISH analysis-a new method for early detection of suspicious oral lesions [J]. Cancer Lett, 2007, 253(2): 282-290. [20] Yarom N, Shani T, Amariglio N, et al. Chromosomal numerical aberrations in oral lichen planus[J]. J Dent Res, 2009, 88(5): 427-432. [21] Castagnola P, Malacarne D, Scaruffi P, et al. Chromosomal aberrations and aneuploidy in oral potentially malignant lesions: distinctive features for tongue [J]. BMC Cancer, 2011, 11: 445. [22] Giaretti W, Maffei M, Pentenero M, et al. Genomic aberrations in normal appearing mucosa fields distal from oral potentially malignant lesions [J]. Cell Oncol (Dordr), 2012, 35(1): 43-52. [23] Pentenero M, Donadini A, Di Nallo E, et al. Field effect in oral precancer as assessed by DNA flow cytometry and array-CGH [J]. J Oral Pathol Med, 2012, 41(2): 119-123. [24] Bremmer JF, Braakhuis BJ, Brink A, et al. Comparative evaluation of genetic assays to identify oral pre-cancerous fields [J]. J Oral Pathol Med, 2008, 37(10): 599-606. [25] Wennerberg J, Baldetorp B, Wahlberg P. Distribution of non-diploid flow-cytometric DNA indices and their relation to the nodal metastasis in squamous cell carcinomas of the head and neck [J]. Invasion Metastasis, 1999, 18(4): 184-191. [26] Hemmer J, Thein T, Van Heerden WF. The value of DNA flow cytometry in predicting the development of lymph node metastasis and survival in patients with locally recurrent oral squamous cell carcinoma [J]. Cancer, 1997, 79(12): 2309-2313. [27] Diwakar N, Sperandio M, Sherriff M, et al. Heterogeneity, histological features and DNA ploidy in oral carcinoma by image-based analysis [J]. Oral Oncol, 2005, 41(4): 416-422. |